Backed by rigorous clinical research and unrivalled educational support, our ablation and cryoablation solutions offer visibility and control, challenging standards of care across a variety of cancers and painful conditions.
What is cryoablation?
Building on our commitment to advancing the field of interventional oncology, Boston Scientific has added the most advanced cryoablation technology to its portfolio of minimally invasive therapies.
Cryoablation is an innovative technology that alternates freezing and thawing to destroy cancer cells. It offers minimally invasive destruction of tumours without the need for open surgery.
Cryoablation can be used to treat renal cell carcinoma, lung, prostate and bone cancer, soft tissue sarcomas and desmoid tumours, among others. It’s also effective in controlling cancer pain.
- Progressive cryoablation software platforms simplify procedure
- Advanced technology drives innovative capabilities
- Flexibility of needle options to tailor your treatment
- Precise control allows you to sculpt your optimal ablation zone
What are the benefits of cryoablation?
Clinical results
MOTION multicentre study: Cryoablation for palliation of painful bone metastases
Multicentre study showing that cryoablation offers effective palliation of painful bone metastases with a corresponding increase in quality of life.
-2.61%
points in pain score in 8 weeks
92%
(59/64) of patients achieved pain palliation
ECLIPSE multicentre study: Cryoablation for the treatment of metastatic lung tumours
Multicentre study showing that cryoablation offers long-term local disease control and favourable survival rates in patients with metastatic lung tumours.
Learn more about ECLIPSE study >
78.2%
Free from local progression at 5 years
79.2%
(per tumour) & 75% (per patients) local control rates at 5 years
Cryoablation indications
With recent innovations in cryoablation and imaging technology, cryoablation is being adopted by an increasing number of physicians to treat a variety of tumour types.
Ablation products portfolio
With game-changing innovation, we’ve streamlined our technology to meet the practical and efficiency demands of your minimally invasive procedures with no compromise to performance.
From market-leading cryoablation systems offering flexibility and control to our radiofrequency product for soft tissue ablation, we offer options for any case.
Featured product:
ICEfxTM Cryoablation System
The next generation of ablation systems with a compact design and interface that offers predictable, reliable performance with seamless therapy delivery and exceptional ease of technical operation.
Caution:
The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France.